Ben Atkins | Vice President-Investor Relations |
Roger Crystal | Chief Executive Officer |
David O'Toole | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Carl Byrnes | Northland Securities |
David Bautz | Zacks |
Greetings. Welcome to the Opiant Pharmaceuticals Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded.